Maria Gabriela Alvarado, David A Schwartz1. 1. From the Department of Anthropology, Georgia State University, Atlanta (Dr Alvarado); and the Department of Pathology, Medical College of Georgia, Augusta University, Augusta (Dr Schwartz).
Abstract
CONTEXT: -The global epidemic of Zika virus (ZIKV) infection has emerged as an important public health problem affecting pregnant women and their infants. OBJECTIVES: -To review the causal association between ZIKV infection during pregnancy and intrauterine fetal infection, microcephaly, brain damage, congenital malformation syndrome, and experimental laboratory models of fetal infection. Many questions remain regarding the risk factors, pathophysiology, epidemiology, and timing of maternal-fetal transmission and disease. These include mechanisms of fetal brain damage and microcephaly; the role of covariables, such as viral burden, duration of viremia, and host genetics, on vertical transmission; and the clinical and pathologic spectrum of congenital Zika syndrome. Additional questions include defining the potential long-term physical and neurobehavioral outcomes for infected infants, whether maternal or fetal host genetics influence the clinical outcome, and whether ZIKV infection can cause maternal morbidity. Finally, are experimental laboratory and animal models of ZIKV infection helpful in addressing maternal-fetal viral transmission and the development of congenital microcephaly? This communication provides current information and attempts to address some of these important questions. DATA SOURCES: -Comprehensive review of published scientific literature. CONCLUSIONS: -Recent advances in epidemiology, clinical medicine, pathology, and experimental studies have provided a great amount of new information regarding vertical ZIKV transmission and the mechanisms of congenital microcephaly, brain damage, and congenital Zika syndrome in a relatively short time. However, much work still needs to be performed to more completely understand the maternal and fetal aspects of this new and emerging viral disease.
CONTEXT: -The global epidemic of Zika virus (ZIKV) infection has emerged as an important public health problem affecting pregnant women and their infants. OBJECTIVES: -To review the causal association between ZIKV infection during pregnancy and intrauterine fetal infection, microcephaly, brain damage, congenital malformation syndrome, and experimental laboratory models of fetal infection. Many questions remain regarding the risk factors, pathophysiology, epidemiology, and timing of maternal-fetal transmission and disease. These include mechanisms of fetal brain damage and microcephaly; the role of covariables, such as viral burden, duration of viremia, and host genetics, on vertical transmission; and the clinical and pathologic spectrum of congenital Zika syndrome. Additional questions include defining the potential long-term physical and neurobehavioral outcomes for infected infants, whether maternal or fetal host genetics influence the clinical outcome, and whether ZIKV infection can cause maternal morbidity. Finally, are experimental laboratory and animal models of ZIKV infection helpful in addressing maternal-fetal viral transmission and the development of congenital microcephaly? This communication provides current information and attempts to address some of these important questions. DATA SOURCES: -Comprehensive review of published scientific literature. CONCLUSIONS: -Recent advances in epidemiology, clinical medicine, pathology, and experimental studies have provided a great amount of new information regarding vertical ZIKV transmission and the mechanisms of congenital microcephaly, brain damage, and congenital Zika syndrome in a relatively short time. However, much work still needs to be performed to more completely understand the maternal and fetal aspects of this new and emerging viral disease.
Authors: Sarah N Cross; Julie A Potter; Paulomi Aldo; Ja Young Kwon; Mary Pitruzzello; Mancy Tong; Seth Guller; Carla V Rothlin; Gil Mor; Vikki M Abrahams Journal: J Immunol Date: 2017-09-15 Impact factor: 5.422
Authors: Jiahui Ding; Anthony Maxwell; Nicholas Adzibolosu; Anna Hu; Yuan You; Aihua Liao; Gil Mor Journal: Immunol Rev Date: 2022-03-20 Impact factor: 10.983
Authors: Tomas S Aleman; Camila V Ventura; Milena M Cavalcanti; Leona W Serrano; Anastasia Traband; Akosua A Nti; Adriana L Gois; Vasco Bravo-Filho; Thayze T Martins; Charles W Nichols; Mauricio Maia; Rubens Belfort Journal: JAMA Ophthalmol Date: 2017-10-01 Impact factor: 7.389
Authors: Maria P Fernandez; Edgar Parra Saad; Martha Ospina Martinez; Sheryl Corchuelo; Marcela Mercado Reyes; Maria Jose Herrera; Miguel Parra Saavedra; Angelica Rico; Angela M Fernandez; Richard K Lee; Camila V Ventura; Audina M Berrocal; Sander R Dubovy Journal: JAMA Ophthalmol Date: 2017-11-01 Impact factor: 7.389